血管形成術用バルーンの市場：タイプ、用途、最終用途別-2025-2030年の世界予測

血管形成術用バルーン市場は、2023年に38億3,000万米ドルと評価され、2024年には41億4,000万米ドルに達すると予測され、CAGR 8.53%で成長し、2030年には68億米ドルになると予測されています。

血管形成術用バルーン市場は、広範な医療機器分野に不可欠であり、特に経皮経管血管形成術で使用される機器に焦点を当てています。これらのバルーンは、狭窄または閉塞した血管を拡張するために不可欠であり、主に心血管疾患の蔓延がその要因となっています。糖尿病や肥満などの生活習慣病の増加により、血管形成術のような高度なインターベンションが必要となり、需要が高まっています。その用途は冠動脈形成術と末梢血管形成術に及び、病院、外来手術センター、診療所が主な最終用途となっています。主な成長要因としては、手技の効率と成果を高める薬剤コーティングや最先端のノンコンプライアントバルーンなどの技術進歩が挙げられます。また、高齢者人口の増加や低侵襲手技に対する認識も、大きな市場成長機会となります。利害関係者は、これらを活用するため、より効率的で患者にやさしく、費用対効果の高いバルーン技術の開発に向けた研究開発の拡大を検討すべきです。医療インフラが急速に改善し、心血管治療への需要が急増している新興国市場にも機会があります。しかし、同市場は、製品上市を遅らせる可能性のある厳しい規制環境や、手頃な価格と利用しやすさに悪影響を及ぼす可能性のあるデバイスに関連する高コストなどの制約に直面しています。また、ステントや医薬品などの代替療法の存在も競合課題となっています。革新的な手段としては、生体吸収性材料の統合、個別化医療のアプローチ、追跡と手技の成功率を高めるデジタルヘルス技術が挙げられます。市場力学は急速な技術進化を特徴としており、持続的な成長を確保するためには技術革新、規制要件、市場力学の最前線に立ち続けることが不可欠です。強固な協力関係やパートナーシップは、この領域におけるプレーヤーの参入・拡大戦略をさらに強化し、より競争的でダイナミックな市場情勢を促進することができます。

市場力学：急速に進化する血管形成術用バルーン市場の主要市場インサイトを公開

血管形成術用バルーン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患の有病率増加と相まって、老年人口の増加
  • 低侵襲手術に対する意識の高まり
  • 経皮的冠動脈インターベンション件数の増加
• 市場抑制要因
  • 血管形成術用バルーンに関連するデザインや材料に関連する制限
• 市場機会
  • 技術の進歩と血管形成術の増加
  • 医学分野における研究開発（R&D）活動の増加
• 市場の課題
  • バルーン血管形成術に伴う合併症

ポーターの5つの力：血管形成術用バルーン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血管形成術用バルーン市場における外部からの影響の把握

外部マクロ環境要因は、血管形成術用バルーン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血管形成術用バルーン市場における競合情勢の把握

血管形成術用バルーン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血管形成術用バルーン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血管形成術用バルーン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血管形成術用バルーン市場における成功への道筋を描く

血管形成術用バルーン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の増加と心血管疾患の罹患率の増加
    • 低侵襲手術に対する意識の高まり
    • 経皮的冠動脈インターベンションの増加
  • 抑制要因
    • 血管形成術用バルーンに関連するデザインと素材に関する制限
  • 機会
    • 技術の進歩と血管形成術の増加
    • 医学における研究開発（R&D）活動の増加
  • 課題
    • バルーン血管形成術に伴う合併症
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血管形成術用バルーンの市場：タイプ別

• 風船を切る
• 薬剤溶出バルーン
• 通常のバルーン
• スコアリングバルーン

第7章 血管形成術用バルーンの市場：用途別

• 冠状
• 周辺

第8章 血管形成術用バルーンの市場：最終用途別

• 外来手術センター
• カテーテル検査室
• 病院

第9章 南北アメリカの血管形成術用バルーンの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の血管形成術用バルーンの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血管形成術用バルーンの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acrostak Int. Distr. Sarl
• Becton, Dickinson and Company
• BIOTRONIK Vertriebs GmbH & Co. KG
• Cardinal Health, Inc.
• Eucatech AG
• Hexacath International
• InSitu Technologies Inc.
• JOTEC GmbH
• Koninklijke Philips N.V
• Medtronic PLC
• MicroPort Scientific Corporation
• Nipro Medical Corporation
• phenox GmbH
• Scitech

LIST OF FIGURES

• FIGURE 1. ANGIOPLASTY BALLOONS MARKET RESEARCH PROCESS
• FIGURE 2. ANGIOPLASTY BALLOONS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANGIOPLASTY BALLOONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANGIOPLASTY BALLOONS MARKET DYNAMICS
• TABLE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CUTTING BALLOONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG ELUTING BALLOONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY NORMAL BALLOONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SCORING BALLOONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CATHETERIZATION LAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 146. ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, 2023

The Angioplasty Balloons Market was valued at USD 3.83 billion in 2023, expected to reach USD 4.14 billion in 2024, and is projected to grow at a CAGR of 8.53%, to USD 6.80 billion by 2030.

The angioplasty balloons market is integral to the broader medical devices sector, focusing specifically on devices used during percutaneous transluminal angioplasty procedures. These balloons are essential for dilating narrowed or obstructed blood vessels, primarily driven by the growing prevalence of cardiovascular diseases. The increased incidence of lifestyle-related conditions such as diabetes and obesity necessitates advanced interventional strategies like angioplasty, thus boosting demand. Their application spans coronary and peripheral angioplasties, with hospitals, ambulatory surgery centers, and clinics serving as primary end-use domains. Key growth factors include technological advancements, such as drug-coated and cutting-edge non-compliant balloons that enhance procedural efficiency and outcomes. Additionally, the growing geriatric population and awareness about minimally invasive procedures present significant market growth opportunities. To capitalize on these, stakeholders should consider expanding R&D to develop more efficient, patient-friendly, and cost-effective balloon technologies. Opportunities also lie in emerging markets where healthcare infrastructure is rapidly improving, and there is a burgeoning demand for cardiovascular treatments. However, the market faces limitations like stringent regulatory environments that can delay product launches and high costs associated with these devices, which can negatively impact affordability and accessibility. The presence of alternative therapies, such as stents and pharmaceuticals, also poses competitive challenges. Innovative avenues include the integration of bioresorbable materials, personalized medicine approaches, and digital health technologies to enhance tracking and procedural success rates. The angioplasty balloons market is characterized by rapid technological evolution, making it imperative for businesses to stay at the forefront of innovation, regulatory requirements, and market dynamics to ensure sustained growth. Robust collaborations and partnerships can further enhance the entry and expansion strategies for players within this domain, fostering a more competitive and dynamic market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Angioplasty Balloons Market

The Angioplasty Balloons Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising geriatric population coupled increasing prevalence of cardiovascular diseases
  • Growing awareness about the minimally invasive surgical procedures
  • Proliferating number of percutaneous coronary interventions
• Market Restraints
  • Limitations associated with design and materials associated with angioplasty balloons
• Market Opportunities
  • Technological advancements and rising angioplasty procedures
  • Increasing research and development (R&D) activities in medical sciences
• Market Challenges
  • Complications associated with baloon angioplasty procedures

Porter's Five Forces: A Strategic Tool for Navigating the Angioplasty Balloons Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Angioplasty Balloons Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Angioplasty Balloons Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Angioplasty Balloons Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Angioplasty Balloons Market

A detailed market share analysis in the Angioplasty Balloons Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Angioplasty Balloons Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Angioplasty Balloons Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Angioplasty Balloons Market

A strategic analysis of the Angioplasty Balloons Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Angioplasty Balloons Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acrostak Int. Distr. Sarl, Becton, Dickinson and Company, BIOTRONIK Vertriebs GmbH & Co. KG, Cardinal Health, Inc., Eucatech AG, Hexacath International, InSitu Technologies Inc., JOTEC GmbH, Koninklijke Philips N.V, Medtronic PLC, MicroPort Scientific Corporation, Nipro Medical Corporation, phenox GmbH, and Scitech.

Market Segmentation & Coverage

This research report categorizes the Angioplasty Balloons Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Cutting Balloons, Drug Eluting Balloons, Normal Balloons, and Scoring Balloons.
• Based on Application, market is studied across Coronary and Peripheral.
• Based on End use, market is studied across Ambulatory Surgery Centers, Catheterization Lab, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising geriatric population coupled increasing prevalence of cardiovascular diseases
    • 5.1.1.2. Growing awareness about the minimally invasive surgical procedures
    • 5.1.1.3. Proliferating number of percutaneous coronary interventions
  • 5.1.2. Restraints
    • 5.1.2.1. Limitations associated with design and materials associated with angioplasty balloons
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and rising angioplasty procedures
    • 5.1.3.2. Increasing research and development (R&D) activities in medical sciences
  • 5.1.4. Challenges
    • 5.1.4.1. Complications associated with baloon angioplasty procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Angioplasty Balloons Market, by Type

• 6.1. Introduction
• 6.2. Cutting Balloons
• 6.3. Drug Eluting Balloons
• 6.4. Normal Balloons
• 6.5. Scoring Balloons

7. Angioplasty Balloons Market, by Application

• 7.1. Introduction
• 7.2. Coronary
• 7.3. Peripheral

8. Angioplasty Balloons Market, by End use

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Catheterization Lab
• 8.4. Hospitals

9. Americas Angioplasty Balloons Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Angioplasty Balloons Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Angioplasty Balloons Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acrostak Int. Distr. Sarl
• 3. Becton, Dickinson and Company
• 4. BIOTRONIK Vertriebs GmbH & Co. KG
• 5. Cardinal Health, Inc.
• 6. Eucatech AG
• 7. Hexacath International
• 8. InSitu Technologies Inc.
• 9. JOTEC GmbH
• 10. Koninklijke Philips N.V
• 11. Medtronic PLC
• 12. MicroPort Scientific Corporation
• 13. Nipro Medical Corporation
• 14. phenox GmbH
• 15. Scitech